{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:05:04Z","timestamp":1787238304276,"version":"build-2736575974"},"reference-count":106,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","cardiology.theclinics.com","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ccl.2017.08.003","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T14:06:27Z","timestamp":1511445987000},"page":"37-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Non\u2013ST-Segment Acute Coronary Syndromes"],"prefix":"10.1016","volume":"36","author":[{"given":"Tarlan","family":"Hedayati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadish","family":"Khanagavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.ccl.2017.08.003_bib1","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1161\/CIR.0000000000000133","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2017.08.003_bib2","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third universal definition of myocardial infarction","volume":"60","author":"Thygesen","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2017.08.003_bib3","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ahj.2008.07.030","article-title":"Trends in presenting characteristics and hospital mortality among patients with ST elevation and non\u2013ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006","volume":"156","author":"Rogers","year":"2008","journal-title":"Am Heart J"},{"issue":"20","key":"10.1016\/j.ccl.2017.08.003_bib4","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1001\/jama.294.20.2623","article-title":"Value and limitations of chest pain history in the evaluation of patients with suspected acute coronary syndromes","volume":"294","author":"Swap","year":"2005","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.ccl.2017.08.003_bib5","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehv029","article-title":"Plaque rupture and intact fibrous cap assessed by optical coherence tomography portend different outcomes in patients with acute coronary syndrome","volume":"36","author":"Niccoli","year":"2015","journal-title":"Eur Heart J"},{"issue":"7","key":"10.1016\/j.ccl.2017.08.003_bib6","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0735-1097(02)02336-7","volume":"40","author":"Braunwald","year":"2002","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.ccl.2017.08.003_bib7","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/S0735-1097(99)00150-3","volume":"33","author":"Gibbons","year":"1999","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2017.08.003_bib8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1097\/HPC.0b013e3181ec36d8","article-title":"Chest pain in the emergency room: a multicenter validation of the HEART Score","volume":"9","author":"Backus","year":"2010","journal-title":"Crit Pathw Cardiol"},{"issue":"3","key":"10.1016\/j.ccl.2017.08.003_bib9","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/j.ijcard.2013.01.255","article-title":"A\u00a0prospective validation of the HEART score for chest pain patients at the emergency department","volume":"168","author":"Backus","year":"2013","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2017.08.003_bib10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCOUTCOMES.114.001384","article-title":"The heart pathway randomized trial identifying emergency department patients with acute chest pain for early discharge","volume":"8","author":"Mahler","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.ccl.2017.08.003_bib11","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jama.284.7.835","article-title":"The TIMI risk score for unstable angina\/non-ST elevation MI: a method for prognostication and therapeutic decision-making","volume":"284","author":"Antman","year":"2000","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ccl.2017.08.003_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/157340311795677662","article-title":"Risk scores for patients with chest pain: evaluation in the emergency department","volume":"7","author":"Backus","year":"2011","journal-title":"Curr Cardiol Rev"},{"issue":"4","key":"10.1016\/j.ccl.2017.08.003_bib13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1136\/emj.2009.077370","article-title":"Oxygen use in acute myocardial infarction: an online survey of health professionals' practice and beliefs","volume":"27","author":"Burls","year":"2010","journal-title":"Emerg Med J"},{"issue":"5","key":"10.1016\/j.ccl.2017.08.003_bib14","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1152\/japplphysiol.00595.2006","article-title":"Effect of hyperoxia and vitamin C on coronary blood flow in patients with ischemic heart disease","volume":"102","author":"McNulty","year":"2007","journal-title":"J\u00a0Appl Physiol"},{"issue":"8","key":"10.1016\/j.ccl.2017.08.003_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007160.pub3","article-title":"Oxygen therapy for acute myocardial infarction","author":"Cabello","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ccl.2017.08.003_bib16","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S0002-9149(83)80117-9","article-title":"Intravenous nitroglycerin for the treatment of angina at rest unresponsive to standard nitrate therapy","volume":"51","author":"Kaplan","year":"1983","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccl.2017.08.003_bib17","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/oxfordjournals.eurheartj.a062327","article-title":"Haemodynamic effects of metoprolol and intravenous nitroglycerin versus metoprolol alone in patients with acute myocardial infarction","volume":"8","author":"Melandri","year":"1987","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccl.2017.08.003_bib18","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S0140-6736(88)91906-X","article-title":"Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials","volume":"1","author":"Yusuf","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2017.08.003_bib19","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.jacc.2003.09.023","article-title":"Time course of the interaction between tadalafil and nitrates","volume":"42","author":"Kloner","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2017.08.003_bib20","first-page":"49","article-title":"Beneficial effect of intravenous nitroglycerin in patients with non-Q myocardial infarction","volume":"35","author":"Charvat","year":"1990","journal-title":"Cardiologia"},{"key":"10.1016\/j.ccl.2017.08.003_bib21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2796.1998.00253.x","article-title":"Intravenous nitroglycerin reduces ischaemia in unstable angina pectoris: a double-blind placebo-controlled study","volume":"243","author":"Karlberg","year":"1998","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib22","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/01.CIR.99.1.168","article-title":"Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee","volume":"99","author":"Cheitlin","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2017.08.003_bib23","doi-asserted-by":"crossref","first-page":"21C","DOI":"10.1016\/S0002-9149(99)00044-2","article-title":"Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist","volume":"83","author":"Webb","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccl.2017.08.003_bib24","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.ahj.2005.02.010","article-title":"Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative","volume":"149","author":"Meine","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccl.2017.08.003_bib25","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1161\/CIRCULATIONAHA.106.616219","article-title":"Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction","volume":"113","author":"Gislason","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2017.08.003_bib26","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials","volume":"332","author":"Kearney","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.ccl.2017.08.003_bib27","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","article-title":"Cardiovascular safety of celecoxib, naproxen, or ibuprofen for arthritis","volume":"375","author":"Nissen","year":"2016","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib28","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1136\/bmj.318.7200.1730","article-title":"Beta blockade after myocardial infarction: systematic review and meta regression analysis","volume":"318","author":"Freemantle","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.ccl.2017.08.003_bib29","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.ahj.2011.01.006","article-title":"Treatment and outcomes in patients with myocardial infarction treated with acute beta-blocker therapy: results from the American College of Cardiology's NCDR((R))","volume":"161","author":"Kontos","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccl.2017.08.003_bib30","first-page":"284","article-title":"A\u00a0systematic review of selective and non-selective beta blockers for prevention of vascular events in patients with acute coronary syndrome or heart failure","volume":"67","author":"de Peuter","year":"2009","journal-title":"Neth J Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib31","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/S0140-6736(05)67661-1","article-title":"Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial","volume":"366","author":"Chen","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2017.08.003_bib32","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM198303173081102","article-title":"A\u00a0double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias","volume":"308","author":"Ryden","year":"1983","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib33","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2017.08.003_bib34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jacc.2004.09.076","article-title":"Antiarrhythmic effect of carvedilol after acute myocardial infarction: results of the carvedilol post-infarct survival control in left ventricular dysfunction (CAPRICORN) trial","volume":"45","author":"McMurray","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2017.08.003_bib35","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM198608143150704","article-title":"Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double blind, randomized, multicenter trial","volume":"315","author":"Gibson","year":"1986","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/0002-9149(91)90773-E","article-title":"Effects of diltiazem on long-term outcome after acute myocardial infarction in patients with and without a history of systemic hypertension. The Multicenter Diltiazem Postinfarction Trial Research Group","volume":"68","author":"Moss","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccl.2017.08.003_bib37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/clc.4960210906","article-title":"Verapamil use in patients with cardiovascular disease: an overview of randomized trials","volume":"21","author":"Pepine","year":"1998","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.ccl.2017.08.003_bib38","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0002-9149(96)00860-0","article-title":"Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study Group","volume":"79","author":"Hansen","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccl.2017.08.003_bib39","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/01.CIR.92.5.1326","article-title":"Nifedipine. Dose-related increase in mortality in patients with coronary heart disease","volume":"92","author":"Furberg","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2017.08.003_bib40","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/hrt.56.5.400","volume":"56","year":"1986","journal-title":"Br Heart J"},{"key":"10.1016\/j.ccl.2017.08.003_bib41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2017.08.003_bib42","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.297.16.1775","article-title":"Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial","volume":"297","author":"Morrow","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2017.08.003_bib43","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.jacc.2009.01.037","article-title":"Efficacy of ranolazine in patients with chronic angina observations from the randomized, double-blind, placebo-controlled MERLIN-TIMI (metabolic efficiency with ranolazine for less ischemia in non-ST-segment elevation acute coronary syndromes) 36 trial","volume":"53","author":"Wilson","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2017.08.003_bib44","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials","volume":"273","author":"Garg","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2017.08.003_bib45","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","article-title":"Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators","volume":"342","author":"Yusuf","year":"2000","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib46","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib47","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0140-6736(08)61242-8","article-title":"Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial","volume":"372","author":"Yusuf","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2017.08.003_bib48","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1016\/j.jacc.2011.04.049","volume":"58","author":"Rossignol","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2017.08.003_bib49","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Dav\u00ec","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib50","unstructured":"Food and Drug Administration. FDA approves new antiplatelet drug used during heart procedure. June 22, 2015."},{"key":"10.1016\/j.ccl.2017.08.003_bib51","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1161\/CIRCULATIONAHA.112.117283","article-title":"Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin","volume":"127","author":"Grosser","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2017.08.003_bib52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ahj.2012.04.001","article-title":"Is there an association between aspirin dosing and cardiac and bleeding events after treatment of acute coronary syndrome? A systematic review of the literature","volume":"164","author":"Berger","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccl.2017.08.003_bib53","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0140-6736(10)61088-4","article-title":"Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomized factorial trial","volume":"376","author":"Mehta","year":"2010","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ccl.2017.08.003_bib54","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/jama.2015.0809","article-title":"Association of NSAID use with risk of bleeding and cardiovascular events in patients receiving antithrombotic therapy after myocardial infarction","volume":"313","author":"Schjerning Olsen","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2017.08.003_bib55","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation","volume":"345","author":"Yusuf","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib56","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2017.08.003_bib57","series-title":"Plavix","year":"2013"},{"key":"10.1016\/j.ccl.2017.08.003_bib58","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.2011.290","article-title":"GRAVITAS Investigators. Standard- vs. high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial","volume":"305","author":"Price","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2017.08.003_bib59","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"TRITON-TIMI 38 investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib60","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1056\/NEJMoa1205512","article-title":"Prasugrel versus clopidogrel for acute coronary syndromes without revascularization","volume":"367","author":"Roe","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib61","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa1308075","article-title":"Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes","volume":"369","author":"Montalescot","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib62","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib63","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","article-title":"Long-term use of ticagrelor in patients with prior myocardial infarction","volume":"372","author":"Bonaca","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib64","unstructured":"The Medicines Company. Kengreal\u2122 (cangrelor) for injection, for intravenous use: US prescribing information. 2015."},{"issue":"14","key":"10.1016\/j.ccl.2017.08.003_bib65","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1300815","article-title":"Effect of platelet inhibition with cangrelor during PCI on ischemic events","volume":"368","author":"Bhatt","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ccl.2017.08.003_bib66","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.amjcard.2015.01.551","article-title":"Overview of the 2014 Food and Drug Administration Cardiovascular and Renal Drugs Advisory Committee meeting regarding cangrelor","volume":"115","author":"Lhermusier","year":"2015","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2017.08.003_bib67","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40256-016-0192-1","article-title":"Optimizing the use of cangrelor in the real world","volume":"17","author":"Qamar","year":"2017","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.ccl.2017.08.003_bib68","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199706123362401","article-title":"Platelet glycoprotein IIb\/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization","volume":"336","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib69","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/01.CIR.100.20.2045","article-title":"Platelet glycoprotein IIb\/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: early benefit during medical treatment only, with additional protection during percutaneous coronary intervention","volume":"100","author":"Boersma","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2017.08.003_bib70","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJM199905273402103","article-title":"Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators","volume":"340","author":"Hamm","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib71","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1056\/NEJM199404073301402","article-title":"Use of a monoclonal antibody directed against the platelet glycoprotein IIb\/IIIa receptor in high-risk coronary angioplasty","volume":"330","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib72","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jama.297.6.591","article-title":"Routine upstream initiation vs deferred selective use of glycoprotein IIb\/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial","volume":"297","author":"Stone","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2017.08.003_bib73","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1056\/NEJMoa0901316","article-title":"Early versus delayed, provisional eptifibatide in acute coronary syndromes","volume":"360","author":"Giugliano","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib74","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0140-6736(00)02324-2","article-title":"Unfractionated heparin and low-molecular-weight heparin in acute coronary syndrome without ST elevation: a meta-analysis","volume":"355","author":"Eikelboom","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2017.08.003_bib75","series-title":"Myocardial Infarction: A Companion to Braunwald\u2019s Heart Disease","first-page":"207","article-title":"Chapter 18. Clinical Practice\/Controversy: Selection of initial anticoagulant therapy","author":"Silvain","year":"2016"},{"key":"10.1016\/j.ccl.2017.08.003_bib76","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0735-1097(00)00808-1","article-title":"Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events","volume":"36","author":"Goodman","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2017.08.003_bib77","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1093\/eurheartj\/ehm224","article-title":"Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysis","volume":"28","author":"Murphy","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccl.2017.08.003_bib78","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/jama.292.1.89","article-title":"Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-segment elevation acute coronary syndromes: a systematic overview","volume":"292","author":"Petersen","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2017.08.003_bib79","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.ahj.2006.08.002","volume":"152","author":"White","year":"2006","journal-title":"Am Heart J"},{"issue":"21","key":"10.1016\/j.ccl.2017.08.003_bib80","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"ACUITY Investigators Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib81","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.jacc.2007.07.042","article-title":"Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial","volume":"50","author":"Mehta","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2017.08.003_bib82","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1001\/jama.2010.1320","article-title":"Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA\/OASIS-8 randomized trial","volume":"304","author":"Steg","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2017.08.003_bib83","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1001\/archinte.163.19.2345","article-title":"Predictors of hospital mortality in the Global Registry of Acute Coronary Events","volume":"163","author":"Granger","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib84","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jacc.2006.06.050","article-title":"Benefit of early invasive therapy in acute coronary syndromes: a meta-analysis of contemporary randomized clinical trials","volume":"48","author":"Bavry","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2017.08.003_bib85","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.jacc.2010.03.007","article-title":"Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome. A meta-analysis of individual patient data","volume":"55","author":"Fox","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2017.08.003_bib86","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jacc.2009.11.026","volume":"55","author":"Damman","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2017.08.003_bib87","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jacc.2015.05.051","article-title":"10-year mortality outcome of a routine invasive strategy versus a selective invasive strategy in non-ST-segment elevation acute coronary syndrome: the British Heart Foundation RITA-3 Randomized Trial","volume":"66","author":"Henderson","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2017.08.003_bib88","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1001\/jama.2009.1267","article-title":"Immediate vs delayed intervention for acute coronary syndromes: a randomized clinical trial","volume":"302","author":"Montalescot","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2017.08.003_bib89","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1093\/eurheartj\/ehr418","article-title":"Optimal timing of invasive angiography in stable non-ST-elevation myocardial infarction: the Leipzig Immediate versus early and late PercutaneouS coronary Intervention triAl in NSTEMI (LIPSIA-NSTEMI trial)","volume":"33","author":"Thiele","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccl.2017.08.003_bib90","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1056\/NEJMoa0807986","article-title":"Early versus delayed invasive intervention in acute coronary syndromes","volume":"360","author":"Mehta","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib91","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4244\/EIJV9I1A9","article-title":"Early or late intervention in high-risk non-ST-elevation acute coronary syndromes: results of the ELISA-3 trial","volume":"9","author":"Badings","year":"2013","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.ccl.2017.08.003_bib92","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/eurheartj\/ehq276","article-title":"Optimal timing of coronary angiography and potential intervention in non-ST-elevation acute coronary syndromes","volume":"32","author":"Katritsis","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccl.2017.08.003_bib93","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/qjmed\/hcq258","article-title":"Early vs. delayed invasive strategy in patients with acute coronary syndromes without ST-segment elevation: a meta-analysis of randomized studies","volume":"104","author":"Navarese","year":"2011","journal-title":"QJM"},{"key":"10.1016\/j.ccl.2017.08.003_bib94","doi-asserted-by":"crossref","first-page":"261","DOI":"10.7326\/0003-4819-158-4-201302190-00006","article-title":"Optimal timing of coronary invasive strategy in non-ST-segment elevation acute coronary syndromes: a systematic review and meta-analysis","volume":"158","author":"Navarese","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccl.2017.08.003_bib95","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ccd.24439","article-title":"Early versus delayed percutaneous coronary intervention for patients with non-ST segment elevation acute coronary syndrome: a meta-analysis of randomized controlled clinical trials","volume":"81","author":"Rajpurohit","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.ccl.2017.08.003_bib96","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1001\/jama.290.12.1593","article-title":"Evaluation of prolonged antithrombotic pretreatment (\u201ccooling-off\u201d strategy) before intervention in patients with unstable coronary syndromes: a randomized controlled trial","volume":"290","author":"Neumann","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2017.08.003_bib97","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/hrt.2008.154815","article-title":"Immediate versus deferred coronary angioplasty in non-ST-segment elevation acute coronary syndromes","volume":"95","author":"Riezebos","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.ccl.2017.08.003_bib98","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/S0195-668X(03)00259-8","article-title":"A\u00a0comparison of two invasive strategies in patients with non-ST elevation acute coronary syndromes: results of the Early or Late Intervention in unStable Angina (ELISA) pilot study. 2b\/3a upstream therapy and acute coronary syndromes","volume":"24","author":"van 't Hof","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccl.2017.08.003_bib99","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jcin.2015.11.018","volume":"9","author":"Milosevic","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.ccl.2017.08.003_bib100","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJM200106213442501","article-title":"Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb\/IIIa inhibitor tirofiban","volume":"344","author":"Cannon","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"10023","key":"10.1016\/j.ccl.2017.08.003_bib101","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(15)01166-6","article-title":"Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomized controlled trial","volume":"387","author":"Tegn","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2017.08.003_bib102","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0735-1097(01)01308-0","article-title":"Is early invasive treatment of unstable coronary artery disease equally effective for both women and men? FRISC II Study Group Investigators","volume":"38","author":"Lagerqvist","year":"2001","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2017.08.003_bib103","series-title":"Treatment strategies for women with coronary artery disease [Internet]","author":"Dolor","year":"2012"},{"key":"10.1016\/j.ccl.2017.08.003_bib104","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1001\/jama.288.24.3124","article-title":"Benefit of an early invasive management strategy in women with acute coronary syndromes","volume":"288","author":"Glaser","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2017.08.003_bib105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.300.1.71","article-title":"Early invasive vs conservative treatment strategies in women and men with unstable angina and non-ST-segment elevation myocardial infarction: a meta-analysis","volume":"300","author":"O'Donoghue","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2017.08.003_bib106","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jacc.2012.02.059","article-title":"An invasive or conservative strategy in patients with diabetes mellitus and non-ST-segment elevation acute coronary syndromes: a collaborative meta-analysis of randomized trials","volume":"60","author":"O'Donoghue","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386511730084X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073386511730084X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T17:22:56Z","timestamp":1535217776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073386511730084X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":106,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S073386511730084X"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2017.08.003","relation":{"is-referenced-by":[{"id-type":"doi","id":"10.1038\/s41598-025-20563-z","asserted-by":"object"}]},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non\u2013ST-Segment Acute Coronary Syndromes","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2017.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}